<DOC>
	<DOCNO>NCT00333151</DOCNO>
	<brief_summary>This trial conduct United States America ( USA ) Canada . This trial design show effect treatment liraglutide add exist rosiglitazone metformin combination therapy compare effect therapy rosiglitazone metformin alone .</brief_summary>
	<brief_title>Effect Liraglutide Blood Glucose Control Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Type 2 diabetes Treated oral antidiabetic ( OAD ) drug least 3 month Treated one OAD moderate poor glycemic control Body Mass Index ( BMI ) less equal 45.0 kg/m2 Treatment insulin within last three month prior trial except due intercurrent illness , discretion Investigator Any serious medical condition Treatment drug could interfere glucose level</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>